Detalhe da pesquisa
1.
Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign.
J Infect Dis
; 227(2): 268-277, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35776140